ORGANOGENESIS HOLDINGS INC. Repayment of Notes Receivable from Related Parties
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Repayment of Notes Receivable from Related Parties of $179.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-11.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RepaymentOfNotesReceivableFromRelatedParties · last filed 2022-03-01
- ORGANOGENESIS HOLDINGS INC. repayment of notes receivable from related parties for the quarter ending 2021-03-31 was $179.00K.
- ORGANOGENESIS HOLDINGS INC. repayment of notes receivable from related parties for the quarter ending 2020-12-31 was -$1.73M.
- ORGANOGENESIS HOLDINGS INC. repayment of notes receivable from related parties for the quarter ending 2020-09-30 was $1.43M.
- ORGANOGENESIS HOLDINGS INC. repayment of notes receivable from related parties for fiscal 2020 was $0.00.
| Period end | Repayment of Notes Receivable from Related Parties 3 month | Repayment of Notes Receivable from Related Parties 6 month | Repayment of Notes Receivable from Related Parties 9 month | Repayment of Notes Receivable from Related Parties 12 month | Repayment of Notes Receivable from Related Parties 12 month as first filed |
|---|---|---|---|---|---|
| 2021-03-31 | $179.00K 10-Q · filed 2021-05-11 | -$1.55M derived: sum of 2 quarters · filed 2022-03-01 | -$114.00K derived: sum of 3 quarters · filed 2022-03-01 | ||
| 2020-12-31 | -$1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$293.00K derived: sum of 2 quarters · filed 2022-03-01 | $0.00 10-K · filed 2022-03-01 | $2.13M 10-K · filed 2021-03-16 | |
| 2020-09-30 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.73M 10-Q · filed 2020-11-09 | |||
| 2020-06-30 | $293.00K 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |